May MIMS update

Some of the recent changes to the medicines landscape, with new products, indications, contraindications, presentations and safety related changes New Products Dexrazoxane (Dexrazoxane-Reach) is an analogue of ethylene diamine tetra-acetic acid. The dose-dependent cardiotoxicity observed during anthracycline administration is due to anthracycline-induced iron-dependent free radical oxidative stress on the relatively unprotected cardiac muscle. Dexrazoxane is